Ranjit Ray - Publications

Affiliations: 
Microbiology Saint Louis University, St. Louis, MO, United States 
Area:
Virology Biology, Microbiology Biology

138 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Haga Y, Meyer K, Sung MMH, Reagan EK, Weissman D, Ray R. Hepatitis C virus modified sE2 as an antigen in candidate vaccine facilitates human immune cell activation. Journal of Virology. e0180923. PMID 38084956 DOI: 10.1128/jvi.01809-23  0.316
2023 Patra T, Meyer K, Haga Y, Reagan EK, Weissman D, Ray R. Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity. Npj Vaccines. 8: 42. PMID 36934116 DOI: 10.1038/s41541-023-00635-9  0.423
2022 Vijayamahantesh V, Patra T, Meyer K, Alameh MG, Reagan EK, Weissman D, Ray R. Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response. Journal of Virology. e0052322. PMID 35612312 DOI: 10.1128/jvi.00523-22  0.464
2021 Khatun M, Zhang J, Ray R, Ray RB. Hepatitis C virus evades IFN signaling by suppressing long non-coding RNA Linc-Pint involving c/EBP-β. Journal of Virology. JVI0095221. PMID 34160260 DOI: 10.1128/JVI.00952-21  0.509
2021 Khatun M, Ray R, Ray RB. Hepatitis C virus associated hepatocellular carcinoma. Advances in Cancer Research. 149: 103-142. PMID 33579422 DOI: 10.1016/bs.acr.2020.10.003  0.441
2020 Khatun M, Sur S, Steele R, Ray R, Ray RB. Inhibition of long noncoding RNA Linc-Pint by hepatitis C virus in infected hepatocytes enhances lipogenesis. Hepatology (Baltimore, Md.). PMID 33236406 DOI: 10.1002/hep.31656  0.521
2020 Patra T, Bose SK, Kwon YC, Meyer K, Ray R. Inhibition of p70 isoforms of S6K1 induces anoikis to prevent transformed human hepatocyte growth. Life Sciences. 118764. PMID 33189822 DOI: 10.1016/j.lfs.2020.118764  0.445
2020 Patra T, Meyer K, Ray RB, Ray R. A combination of AZD5363 and FH5363 induces lethal autophagy in transformed hepatocytes. Cell Death & Disease. 11: 540. PMID 32681102 DOI: 10.1038/S41419-020-02741-1  0.319
2020 Kwon YC, Sasaki R, Meyer K, Ray R. Correction for Kwon et al., "Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis". Journal of Virology. 94. PMID 32611689 DOI: 10.1128/Jvi.00629-20  0.404
2020 Nazzal M, Sur S, Steele R, Khatun M, Patra T, Phillips N, Long J, Ray R, Ray RB. Establishment of a PDX tumor from Hepatitis C Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy. Hepatology (Baltimore, Md.). PMID 32356575 DOI: 10.1002/Hep.31298  0.422
2019 Patra T, Meyer K, Ray RB, Ray R. Hepatitis C virus mediated inhibition of miR-181c activates ATM signaling and promotes hepatocyte growth. Hepatology (Baltimore, Md.). PMID 31400158 DOI: 10.1002/Hep.30893  0.47
2019 Patra T, Sasaki R, Meyer K, Ray RB, Ray R. TGF-β acts as a regulatory molecule for lipogenic pathway among hepatitis C virus genotype specific infection. Journal of Virology. PMID 31243135 DOI: 10.1128/Jvi.00811-19  0.564
2019 Patra T, Ray RB, Ray R. Strategies to Circumvent Host Innate Immune Response by Hepatitis C Virus. Cells. 8. PMID 30909456 DOI: 10.3390/Cells8030274  0.519
2019 Kwon YC, Ray R. Complement Regulation and Immune Evasion by Hepatitis C Virus. Methods in Molecular Biology (Clifton, N.J.). 1911: 337-347. PMID 30593637 DOI: 10.1007/978-1-4939-8976-8_23  0.567
2018 Sasaki R, Meyer K, Moriyama M, Kato N, Yokosuka O, Ray RB, Aurora R, Ray R, Kanda T. Rapid hepatitis C virus clearance by antivirals correlates with immune status of infected patients. Journal of Medical Virology. PMID 30192392 DOI: 10.1002/Jmv.25310  0.598
2018 Ray RB, Ray R. Hepatitis C virus manipulates humans as its favorite host for long term relationship. Hepatology (Baltimore, Md.). PMID 30102776 DOI: 10.1002/Hep.30214  0.544
2018 Sur S, Sasaki R, Devhare P, Steele R, Ray R, Ray RB. Association between microRNA-373 and long non-coding RNA NORAD in hepatitis C virus infected hepatocytes impairs Wee1 expression for growth promotion. Journal of Virology. PMID 30089699 DOI: 10.1128/Jvi.01215-18  0.528
2018 Kwon YC, Meyer K, Peng G, Chatterjee S, Hoft DF, Ray R. Hepatitis C virus E2 envelope glycoprotein induces an immunoregulatory phenotype in macrophages. Hepatology (Baltimore, Md.). PMID 29443378 DOI: 10.1002/Hep.29843  0.564
2017 Kim H, Bose SK, Meyer K, Ray R. Correction for Kim et al., "Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis". Journal of Virology. 91. PMID 29191984 DOI: 10.1128/Jvi.01590-17  0.587
2017 Devhare P, Meyer K, Steele R, Ray RB, Ray R. Zika virus infection dysregulates human neural stem cell growth and inhibits differentiation into neuroprogenitor cells. Cell Death & Disease. 8: e3106. PMID 29022904 DOI: 10.1038/Cddis.2017.517  0.423
2017 Meyer K, Kwon YC, Ray RB, Ray R. N-terminal gelsolin fragment potentiates TRAIL mediated death in resistant hepatoma cells. Scientific Reports. 7: 12803. PMID 28993697 DOI: 10.1038/S41598-017-13131-7  0.316
2017 Kwon YC, Sasaki R, Meyer K, Ray R. HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS. Journal of Virology. PMID 28794048 DOI: 10.1128/Jvi.01235-17  0.602
2017 Sasaki R, Devhare P, Ray RB, Ray R. Hepatitis C virus induced tumor initiating cancer stem-like cells activate stromal fibroblasts in xenograft tumor model. Hepatology (Baltimore, Md.). PMID 28664988 DOI: 10.1002/Hep.29346  0.587
2017 Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB. Correction for Devhare et al., "Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells". Journal of Virology. 91. PMID 28455354 DOI: 10.1128/Jvi.00349-17  0.477
2017 Sasaki R, Devhare PB, Steele R, Ray R, Ray RB. Hepatitis C virus induced CCL5 secretion from macrophages activates hepatic stellate cells. Hepatology (Baltimore, Md.). PMID 28318046 DOI: 10.1002/Hep.29170  0.593
2017 Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB. Exosome mediated intercellular communication between hepatitis C virus infected hepatocytes and hepatic stellate cells. Journal of Virology. PMID 28077652 DOI: 10.1128/Jvi.02225-16  0.62
2016 Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R. Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus. Journal of Immunology (Baltimore, Md. : 1950). PMID 27357152 DOI: 10.4049/Jimmunol.1600631  0.614
2015 Shrivastava S, Devhare P, Sujijantarat N, Steele R, Kwon YC, Ray R, Ray RB. Knockdown of autophagy inhibits infectious hepatitis C virus release by exosomal pathway. Journal of Virology. PMID 26581990 DOI: 10.1128/Jvi.02383-15  0.621
2015 Kwon YC, Bose SK, Steele R, Meyer K, Di Bisceglie AM, Ray RB, Ray R. PROMOTION OF CANCER STEM-LIKE CELL PROPERTIES IN HEPATITIS C VIRUS INFECTED HEPATOCYTES. Journal of Virology. PMID 26355082 DOI: 10.1128/Jvi.01946-15  0.712
2015 Kachko A, Frey SE, Sirota L, Ray R, Wells F, Zubkova I, Zhang P, Major ME. Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity. Hepatology (Baltimore, Md.). PMID 26251214 DOI: 10.1002/Hep.28108  0.49
2015 Shrivastava S, Steele R, Ray R, Ray RB. MicroRNAs: Role in Hepatitis C Virus pathogenesis. Genes & Diseases. 2: 35-45. PMID 25984557 DOI: 10.1016/J.Gendis.2015.01.001  0.577
2015 Meyer K, Kwon YC, Liu S, Hagedorn CH, Ray RB, Ray R. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection. Scientific Reports. 5: 9012. PMID 25757571 DOI: 10.1038/Srep09012  0.591
2014 Kwon YC, Ray RB, Ray R. Hepatitis C virus infection: establishment of chronicity and liver disease progression. Excli Journal. 13: 977-96. PMID 26417315  0.352
2014 Kim H, Meyer K, Di Bisceglie AM, Ray R. Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components. Plos One. 9: e101422. PMID 24983375 DOI: 10.1371/Journal.Pone.0101422  0.62
2014 Mukherjee A, Shrivastava S, Bhanja Chowdhury J, Ray R, Ray RB. Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression. Journal of Virology. 88: 7929-40. PMID 24789793 DOI: 10.1128/Jvi.00787-14  0.529
2014 Kim H, Ray R. Evasion of TNF-α-mediated apoptosis by hepatitis C virus. Methods in Molecular Biology (Clifton, N.J.). 1155: 125-32. PMID 24788178 DOI: 10.1007/978-1-4939-0669-7_11  0.566
2014 Bose SK, Ray R. Hepatitis C virus infection and insulin resistance. World Journal of Diabetes. 5: 52-8. PMID 24567801 DOI: 10.4239/Wjd.V5.I1.52  0.679
2014 Bose SK, Kim H, Meyer K, Wolins N, Davidson NO, Ray R. Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. Journal of Virology. 88: 4195-203. PMID 24478438 DOI: 10.1128/Jvi.03327-13  0.715
2014 Kim H, Bose SK, Meyer K, Ray R. Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis. Journal of Virology. 88: 2564-71. PMID 24352446 DOI: 10.1128/Jvi.02988-13  0.721
2014 Chowdhury JB, Kim H, Ray R, Ray RB. Hepatitis C virus NS5A protein modulates IRF-7-mediated interferon-α signaling. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 34: 16-21. PMID 23962002 DOI: 10.1089/Jir.2013.0038  0.612
2014 Ray RB, Mukherjee A, Shrivastava S, Ray R. Abstract 3177: Hepatitis C virus transcriptionally downregulates miR-181c for promotion of hepatocyte growth towards hepatocellular carcinoma Cancer Research. 74: 3177-3177. DOI: 10.1158/1538-7445.Am2014-3177  0.523
2013 Shrivastava S, Mukherjee A, Ray R, Ray RB. Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages. Journal of Virology. 87: 12284-90. PMID 24006444 DOI: 10.1128/Jvi.01962-13  0.478
2013 Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB, Diamond MS, Atkinson JP, Ray R. Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles. Journal of Virology. 87: 7902-10. PMID 23658447 DOI: 10.1128/Jvi.00917-13  0.695
2013 Kim H, Meyer K, Di Bisceglie AM, Ray R. Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function. Journal of Virology. 87: 5858-67. PMID 23487461 DOI: 10.1128/Jvi.00174-13  0.636
2013 Bose SK, Ray R. Association of lipid droplet and hepatitis C virus proteins: insights for virus replication. Journal of Lipid Research. 54: 871-2. PMID 23402989 DOI: 10.1194/Jlr.E036772  0.712
2012 Bose SK, Meyer K, Di Bisceglie AM, Ray RB, Ray R. Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes. Journal of Virology. 86: 13621-8. PMID 23035229 DOI: 10.1128/Jvi.02016-12  0.701
2012 Mazumdar B, Meyer K, Ray R. N-terminal region of gelsolin induces apoptosis of activated hepatic stellate cells by a caspase-dependent mechanism. Plos One. 7: e44461. PMID 22952982 DOI: 10.1371/Journal.Pone.0044461  0.384
2012 Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. Journal of Virology. 86: 10221-5. PMID 22787204 DOI: 10.1128/Jvi.00882-12  0.492
2012 Kim H, Mazumdar B, Bose SK, Meyer K, Di Bisceglie AM, Hoft DF, Ray R. Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface. Journal of Virology. 86: 9919-28. PMID 22761382 DOI: 10.1128/Jvi.00388-12  0.736
2012 Shrivastava S, Bhanja Chowdhury J, Steele R, Ray R, Ray RB. Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. Journal of Virology. 86: 8705-12. PMID 22674982 DOI: 10.1128/Jvi.00616-12  0.626
2012 Bose SK, Shrivastava S, Meyer K, Ray RB, Ray R. Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. Journal of Virology. 86: 6315-22. PMID 22457523 DOI: 10.1128/Jvi.00050-12  0.71
2012 Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB, Ray R. Hepatitis C virus proteins inhibit C3 complement production. Journal of Virology. 86: 2221-8. PMID 22171262 DOI: 10.1128/Jvi.06577-11  0.718
2011 Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. Journal of Virology. 85: 12881-9. PMID 21976647 DOI: 10.1128/Jvi.05633-11  0.643
2011 Meyer K, Banerjee A, Frey SE, Belshe RB, Ray R. A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection. Plos One. 6: e23699. PMID 21887300 DOI: 10.1371/Journal.Pone.0023699  0.618
2011 Ray R. Progress toward development of a hepatitis C vaccine with broad shoulders. Science Translational Medicine. 3: 94ps33. PMID 21813753 DOI: 10.1126/Scitranslmed.3002772  0.555
2011 Mazumdar B, Banerjee A, Meyer K, Ray R. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology (Baltimore, Md.). 54: 1149-56. PMID 21735466 DOI: 10.1002/Hep.24523  0.497
2011 Banerjee A, Mazumdar B, Meyer K, Di Bisceglie AM, Ray RB, Ray R. Transcriptional repression of C4 complement by hepatitis C virus proteins. Journal of Virology. 85: 4157-66. PMID 21345967 DOI: 10.1128/Jvi.02449-10  0.619
2011 Shrivastava S, Raychoudhuri A, Steele R, Ray R, Ray RB. Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology (Baltimore, Md.). 53: 406-14. PMID 21274862 DOI: 10.1002/Hep.24073  0.618
2010 Banerjee A, Ray RB, Ray R. Oncogenic potential of hepatitis C virus proteins. Viruses. 2: 2108-33. PMID 21994721 DOI: 10.3390/V2092108  0.631
2010 Raychoudhuri A, Shrivastava S, Steele R, Dash S, Kanda T, Ray R, Ray RB. Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes. Journal of Virology. 84: 10991-8. PMID 20810735 DOI: 10.1128/Jvi.00900-10  0.604
2010 Ray R, Meyer K, Banerjee A, Basu A, Coates S, Abrignani S, Houghton M, Frey SE, Belshe RB. Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins. The Journal of Infectious Diseases. 202: 862-6. PMID 20677942 DOI: 10.1086/655902  0.561
2010 Frey SE, Houghton M, Coates S, Abrignani S, Chien D, Rosa D, Pileri P, Ray R, Di Bisceglie AM, Rinella P, Hill H, Wolff MC, Schultze V, Han JH, Scharschmidt B, et al. Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. Vaccine. 28: 6367-73. PMID 20619382 DOI: 10.1016/J.Vaccine.2010.06.084  0.575
2010 Banerjee A, Meyer K, Mazumdar B, Ray RB, Ray R. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. Journal of Virology. 84: 5936-46. PMID 20357092 DOI: 10.1128/Jvi.02344-09  0.607
2010 Ait-Goughoulte M, Banerjee A, Meyer K, Mazumdar B, Saito K, Ray RB, Ray R. Hepatitis C virus core protein interacts with fibrinogen-beta and attenuates cytokine stimulated acute-phase response. Hepatology (Baltimore, Md.). 51: 1505-13. PMID 20162731 DOI: 10.1002/Hep.23502  0.505
2009 Banerjee A, Saito K, Meyer K, Banerjee S, Ait-Goughoulte M, Ray RB, Ray R. Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition. Journal of Virology. 83: 9663-71. PMID 19605487 DOI: 10.1128/Jvi.00872-09  0.617
2009 Kanda T, Steele R, Ray R, Ray RB. Inhibition of intrahepatic gamma interferon production by hepatitis C virus nonstructural protein 5A in transgenic mice. Journal of Virology. 83: 8463-9. PMID 19553305 DOI: 10.1128/Jvi.00751-09  0.558
2008 Kanda T, Steele R, Ray R, Ray RB. Hepatitis C virus core protein augments androgen receptor-mediated signaling. Journal of Virology. 82: 11066-72. PMID 18768969 DOI: 10.1128/Jvi.01300-08  0.607
2008 Saito K, Ait-Goughoulte M, Truscott SM, Meyer K, Blazevic A, Abate G, Ray RB, Hoft DF, Ray R. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. Journal of Virology. 82: 3320-8. PMID 18216090 DOI: 10.1128/Jvi.02547-07  0.592
2008 Banerjee S, Saito K, Ait-Goughoulte M, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance. Journal of Virology. 82: 2606-12. PMID 18160431 DOI: 10.1128/Jvi.01672-07  0.551
2008 Meyer K, Ait-Goughoulte M, Keck ZY, Foung S, Ray R. Antibody-dependent enhancement of hepatitis C virus infection. Journal of Virology. 82: 2140-9. PMID 18094180 DOI: 10.1128/Jvi.01867-07  0.614
2008 Ait-Goughoulte M, Kanda T, Meyer K, Ryerse JS, Ray RB, Ray R. Hepatitis C virus genotype 1a growth and induction of autophagy. Journal of Virology. 82: 2241-9. PMID 18077704 DOI: 10.1128/Jvi.02093-07  0.611
2007 Kanda T, Steele R, Ray R, Ray RB. Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. Journal of Virology. 81: 12375-81. PMID 17804510 DOI: 10.1128/Jvi.01695-07  0.62
2007 Basu A, Kanda T, Beyene A, Saito K, Meyer K, Ray R. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. Journal of Virology. 81: 3933-41. PMID 17287282 DOI: 10.1128/Jvi.02622-06  0.625
2007 Kanda T, Steele R, Ray R, Ray RB. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect. Journal of Virology. 81: 669-76. PMID 17079316 DOI: 10.1128/Jvi.01496-06  0.625
2006 Basu A, Saito K, Meyer K, Ray RB, Friedman SL, Chang YH, Ray R. Stellate cell apoptosis by a soluble mediator from immortalized human hepatocytes. Apoptosis : An International Journal On Programmed Cell Death. 11: 1391-400. PMID 16830231 DOI: 10.1007/S10495-006-8312-Z  0.494
2006 Kanda T, Basu A, Steele R, Wakita T, Ryerse JS, Ray R, Ray RB. Generation of infectious hepatitis C virus in immortalized human hepatocytes. Journal of Virology. 80: 4633-9. PMID 16611923 DOI: 10.1128/Jvi.80.9.4633-4639.2006  0.606
2006 Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R. Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. Journal of Virology. 80: 4372-9. PMID 16611896 DOI: 10.1128/Jvi.80.9.4372-4379.2006  0.548
2006 Basu A, Meyer K, Lai KK, Saito K, Di Bisceglie AM, Grosso LE, Ray RB, Ray R. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology. 349: 347-58. PMID 16545852 DOI: 10.1016/J.Virol.2006.02.023  0.581
2006 Morishima C, Polyak SJ, Ray R, Doherty MC, Di Bisceglie AM, Malet PF, Bonkovsky HL, Sullivan DG, Gretch DR, Rothman AL, Koziel MJ, Lindsay KL. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. The Journal of Infectious Diseases. 193: 931-40. PMID 16518754 DOI: 10.1086/500952  0.584
2006 Frey S, Gorse G, DiBisceglie A, Rosa D, Stamataki Z, McKeating J, Ray R, Coates S, Schultze V, Abrignan S, Houghton M, Hill H, Belshe R. O.015 A phase 1 trial of a novel E1E2/MF59C.1 hepatitis C vaccine candidate in healthy HCV-negative adults (DMID 01-002) Journal of Clinical Virology. 36: S5. DOI: 10.1016/S1386-6532(06)80024-7  0.468
2005 Meyer K, Basu A, Saito K, Ray RB, Ray R. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death. Virology. 336: 198-207. PMID 15892961 DOI: 10.1016/J.Virol.2005.03.016  0.555
2005 Rothman AL, Morishima C, Bonkovsky HL, Polyak SJ, Ray R, Di Bisceglie AM, Lindsay KL, Malet PF, Chang M, Gretch DR, Sullivan DG, Bhan AK, Wright EC, Koziel MJ. Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology (Baltimore, Md.). 41: 617-25. PMID 15726656 DOI: 10.1002/Hep.20581  0.595
2004 Meyer K, Beyene A, Bowlin TL, Basu A, Ray R. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer. Journal of Virology. 78: 12838-47. PMID 15542636 DOI: 10.1128/Jvi.78.23.12838-12847.2004  0.438
2004 Basu A, Steele R, Ray R, Ray RB. Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. The Journal of General Virology. 85: 2299-306. PMID 15269371 DOI: 10.1099/Vir.0.80028-0  0.55
2004 Beyene A, Basu A, Meyer K, Ray R. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity. Virology. 324: 273-85. PMID 15207615 DOI: 10.1016/J.Virol.2004.03.039  0.442
2004 Basu A, Beyene A, Meyer K, Ray R. The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system. Journal of Virology. 78: 4478-86. PMID 15078928 DOI: 10.1128/Jvi.78.9.4478-4486.2004  0.443
2004 Sarcar B, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology. 322: 51-60. PMID 15063116 DOI: 10.1016/J.Virol.2004.01.008  0.596
2004 Ray RB, Basu A, Steele R, Beyene A, McHowat J, Meyer K, Ghosh AK, Ray R. Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells. Virology. 321: 181-8. PMID 15051379 DOI: 10.1016/J.Virol.2003.12.014  0.313
2003 Majumder M, Steele R, Ghosh AK, Zhou XY, Thornburg L, Ray R, Phillips NJ, Ray RB. Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. Febs Letters. 555: 528-32. PMID 14675768 DOI: 10.1016/S0014-5793(03)01337-1  0.624
2003 Sen A, Steele R, Ghosh AK, Basu A, Ray R, Ray RB. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Research. 96: 27-35. PMID 12951263 DOI: 10.1016/S0168-1702(03)00170-9  0.616
2003 Ghosh AK, Majumder M, Steele R, Ray R, Ray RB. Modulation of interferon expression by hepatitis C virus NS5A protein and human homeodomain protein PTX1. Virology. 306: 51-9. PMID 12620797 DOI: 10.1016/S0042-6822(02)00029-6  0.595
2003 Rothman A, Morishima C, Ray R, Chang M, Bonkovsky H, Dibisceglie A, Lee W, Lindsay K, Gretch D, Sullivan D. 636 Host immune responses do not correlate with histologic injury: Baseline analysis of the halt-C trial in advanced hepatitis C disease Hepatology. 38: 467-467. DOI: 10.1016/S0270-9139(03)80678-X  0.347
2003 MORISHIMA C, RAY R, POLYAK S, SULLIVAN D, DIBISCEGLIE A, LEE W, BONKOVSKY H, GRETCH D, WRIGHT E, ROTHMAN A. 221 HCV-specific immune responses at baseline do not predict virologic response to antiviral therapy in advanced hepatitis C Hepatology. 38: 263-263. DOI: 10.1016/S0270-9139(03)80264-1  0.522
2002 Beyene A, Basu A, Meyer K, Ray R. Hepatitis C virus envelope glycoproteins and potential for vaccine development. Vox Sanguinis. 83: 27-32. PMID 12617098 DOI: 10.1111/J.1423-0410.2002.Tb05262.X  0.629
2002 Ray RB, Steele R, Basu A, Meyer K, Majumder M, Ghosh AK, Ray R. Distinct functional role of Hepatitis C virus core protein on NF-kappaB regulation is linked to genomic variation. Virus Research. 87: 21-9. PMID 12135786 DOI: 10.1016/S0168-1702(02)00046-1  0.588
2002 Basu A, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology. 298: 53-62. PMID 12093173 DOI: 10.1006/Viro.2002.1460  0.574
2002 Lagging LM, Meyer K, Westin J, Wejstål R, Norkrans G, Lindh M, Ray R. Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients. The Journal of Infectious Diseases. 185: 1165-9. PMID 11930327 DOI: 10.1086/339679  0.578
2002 Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology. 294: 94-105. PMID 11886269 DOI: 10.1006/Viro.2001.1309  0.524
2002 Meyer K, Basu A, Przysiecki CT, Lagging LM, Di Bisceglie AM, Conley AJ, Ray R. Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein. Journal of Virology. 76: 2150-8. PMID 11836392 DOI: 10.1128/Jvi.76.5.2150-2158.2002  0.586
2002 Ray RB, Ray R. Tumor suppressor genes in human hepatocellular carcinoma Perspectives in Medical Virology. 6: 85-92. DOI: 10.1016/S0168-7069(02)06067-6  0.358
2001 Basu A, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene. Virology. 288: 379-90. PMID 11601909 DOI: 10.1006/Viro.2001.1100  0.598
2001 Ray RB, Ray R. Hepatitis C virus core protein: intriguing properties and functional relevance Fems Microbiology Letters. 202: 149-156. PMID 11520607 DOI: 10.1111/J.1574-6968.2001.Tb10796.X  0.635
2001 Ray R, Hoft DF, Meyer K, Brown R, Lagging LM, Belshe RB. Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus. Virus Research. 75: 147-54. PMID 11325469 DOI: 10.1016/S0168-1702(01)00237-4  0.34
2001 Majumder M, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C Virus NS5A Physically Associates with p53 and Regulates p21/waf1 Gene Expression in a p53-Dependent Manner Journal of Virology. 75: 1401-1407. PMID 11152513 DOI: 10.1128/Jvi.75.3.1401-1407.2001  0.454
2000 Meyer K, Basu A, Ray R. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells. Virology. 276: 214-226. PMID 11022009 DOI: 10.1006/Viro.2000.0547  0.602
2000 Ghosh AK, Majumder M, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death Virus Research. 67: 173-178. PMID 10867196 DOI: 10.1016/S0168-1702(00)00141-6  0.559
2000 Ray RB, Meyer K, Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology. 271: 197-204. PMID 10814584 DOI: 10.1006/Viro.2000.0295  0.621
2000 Ghosh AK, Majumder M, Steele R, Yaciuk P, Chrivia J, Ray R, Ray RB. Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP Journal of Biological Chemistry. 275: 7184-7188. PMID 10702287 DOI: 10.1074/Jbc.275.10.7184  0.478
1999 Ghosh AK, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. Journal of General Virology. 80: 1179-1183. PMID 10355764 DOI: 10.1099/0022-1317-80-5-1179  0.447
1999 Ray RB, Ghosh AK, Meyer K, Ray R. Functional analysis of a transrepressor domain in the hepatitis C virus core protein. Virus Research. 59: 211-217. PMID 10082392 DOI: 10.1016/S0168-1702(98)00138-5  0.525
1998 Shrivastava A, Manna SK, Ray R, Aggarwal BB. Ectopic Expression of Hepatitis C Virus Core Protein Differentially Regulates Nuclear Transcription Factors Journal of Virology. 72: 9722-9728. PMID 9811706 DOI: 10.1128/Jvi.72.12.9722-9728.1998  0.488
1998 Lagging LM, Meyer K, Owens RJ, Ray R. Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus Journal of Virology. 72: 3539-3546. PMID 9557633 DOI: 10.1128/Jvi.72.5.3539-3546.1998  0.599
1998 Ray RB, Steele R, Meyer K, Ray R. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity Gene. 208: 331-336. PMID 9524287 DOI: 10.1016/S0378-1119(98)00030-4  0.621
1997 Ray RB, Steele R, Meyer K, Ray R. Transcriptional Repression of p53 Promoter by Hepatitis C Virus Core Protein Journal of Biological Chemistry. 272: 10983-10986. PMID 9110985 DOI: 10.1074/Jbc.272.17.10983  0.604
1996 Ray RB, Meyer K, Ray R. Suppression of Apoptotic Cell Death by Hepatitis C Virus Core Protein Virology. 226: 176-182. PMID 8955036 DOI: 10.1006/Viro.1996.0644  0.616
1996 Srinivas RV, Ray RB, Meyer K, Ray R. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Research. 45: 87-92. PMID 8896243 DOI: 10.1016/S0168-1702(96)01361-5  0.547
1996 Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. Journal of Virology. 70: 4438-4443. PMID 8676467 DOI: 10.1128/Jvi.70.7.4438-4443.1996  0.61
1996 Ray R, Galinski MS, Heminway BR, Meyer K, Newman FK, Belshe RB. Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene. Journal of Virology. 70: 580-4. PMID 8523574 DOI: 10.1128/Jvi.70.1.580-584.1996  0.363
1995 Ray RB, Lagging LM, Meyer K, Steele R, Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein Virus Research. 37: 209-220. PMID 8533458 DOI: 10.1016/0168-1702(95)00034-N  0.597
1995 Ray R, Meyer K, Newman FK, Belshe RB. Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain. Journal of Virology. 69: 1959-63. PMID 7853542 DOI: 10.1128/Jvi.69.3.1959-1963.1995  0.387
1995 Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. Journal of Virology. 69: 5859-63. PMID 7637033 DOI: 10.1128/Jvi.69.9.5859-5863.1995  0.603
1995 Khanna A, Ray R. Hepatitis C virus core protein: synthesis, affinity purification and immunoreactivity with infected human sera Gene. 153: 185-189. PMID 7533115 DOI: 10.1016/0378-1119(94)00782-N  0.606
1994 Ray R, Khanna A, Lagging LM, Meyer K, Choo QL, Ralston R, Houghton M, Becherer PR. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. Journal of Virology. 68: 4420-6. PMID 8207814 DOI: 10.1128/Jvi.68.7.4420-4426.1994  0.562
1994 Khanna A, Naik SR, Thyagarajan SP, Talwar GP, Ray R. Seroreactivity and genomic amplification profile of hepatitis C virus from patients with chronic liver disease in India. The American Journal of the Medical Sciences. 307: 144-50. PMID 8141141 DOI: 10.1097/00000441-199402000-00014  0.424
1993 Ray R, Novak M, Duncan JD, Matsuoka Y, Compans RW. Microencapsulated human parainfluenza virus induces a protective immune response. The Journal of Infectious Diseases. 167: 752-5. PMID 8382726 DOI: 10.1093/Infdis/167.3.752  0.399
1992 Ray R, Jameel S, Manivel V, Ray R. Indian hepatitis E virus shows a major deletion in the small open reading frame. Virology. 189: 359-362. PMID 1534953 DOI: 10.1016/0042-6822(92)90716-3  0.388
1992 Ray R, Duncan J, Quinn R, Matsuoka Y. Distinct hemagglutinin and neuraminidase epitopes involved in antigenic variation of recent human parainfluenza virus type 2 isolates Virus Research. 24: 107-113. PMID 1378237 DOI: 10.1016/0168-1702(92)90034-7  0.344
1992 Hu X, Ray R, Compans RW. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses Journal of Virology. 66: 1528-1534. PMID 1310764 DOI: 10.1128/Jvi.66.3.1528-1534.1992  0.308
1991 Matsuoka Y, Curran J, Pelet T, Kolakofsky D, Ray R, Compans RW. The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. Journal of Virology. 65: 3406-3410. DOI: 10.1128/Jvi.65.6.3406-3410.1991  0.31
1990 Hu X, Compans RW, Matsuoka Y, Ray R. Molecular cloning and sequence analysis of the fusion glycoprotein gene of human parainfluenza virus type 2 Virology. 179: 915-920. PMID 2173268 DOI: 10.1016/0042-6822(90)90168-Q  0.303
1990 Ray R, Matsuoka Y, Burnett TL, Glaze BJ, Compans RW. Human parainfluenza virus induces a type-specific protective immune response. The Journal of Infectious Diseases. 162: 746-9. PMID 2167342 DOI: 10.1093/Infdis/162.3.746  0.374
1990 Matsuoka Y, Ray R, Compans RW. Sequence of the hemagglutinin-neuraminidase gene of human parainfluenza virus type 1 Virus Research. 16: 107-113. PMID 2161592 DOI: 10.1016/0168-1702(90)90047-F  0.311
1989 Ray R, Galinski MS, Compans RW. Expression of the fusion glycoprotein of human parainfluenza type 3 virus in insect cells by a recombinant baculovirus and analysis of its immunogenic property Virus Research. 12: 169-180. PMID 2539707 DOI: 10.1016/0168-1702(89)90062-2  0.411
1988 Ray R, Glaze BJ, Moldoveanu Z, Compans RW. Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3. The Journal of Infectious Diseases. 157: 648-54. PMID 2831281 DOI: 10.1093/Infdis/157.4.648  0.344
1988 Ray R, Glaze BJ, Compans RW. Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response Journal of Virology. 62: 783-787. PMID 2828674 DOI: 10.1128/Jvi.62.3.783-787.1988  0.349
1987 Ray R, Compans RW. Glycoproteins of human parainfluenza virus type 3: Affinity purification, antigenic characterization and reconstruction into lipid vesicles Journal of General Virology. 68: 409-418. PMID 3029283 DOI: 10.1099/0022-1317-68-2-409  0.344
1986 Ray R, Compans RW. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses. Virology. 148: 232-6. PMID 2417412 DOI: 10.1016/0042-6822(86)90420-4  0.311
1985 Ray R, Brown VE, Compans RW. Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine. The Journal of Infectious Diseases. 152: 1219-30. PMID 2999259 DOI: 10.1093/Infdis/152.6.1219  0.353
Show low-probability matches.